Related Experiment Video
Updated: Dec 4, 2025

04:54
Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs
Published on: May 3, 2024
1.1K
Extracellular vesicles from organoids and 3D culture systems
1Department of Human Genetics, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Biotechnology and Bioengineering
|October 21, 2020
Summary
Extracellular vesicles (EVs) are crucial for cell communication, transporting vital molecules. This review details progress in analyzing EVs using 3D organoid models and discusses their therapeutic potential.
Area of Science:
- Cell Biology
- Biotechnology
- Nanomedicine
Background:
- Extracellular vesicles (EVs), including exosomes, were initially considered cellular waste disposal mechanisms.
- EVs are now recognized as critical mediators of intercellular communication, transporting RNA, DNA, and bioactive molecules.
- Research on EVs has expanded from body fluids and 2D cultures to advanced 3D multicellular in vitro models.
Purpose of the Study:
- To provide a comprehensive overview of progress in analyzing EVs using 3D in vitro culture models.
- To highlight the potential of 3D models for studying EVs in physiological and pathological contexts.
- To briefly discuss translational efforts and regulatory considerations for EV-based therapeutics.
Main Methods:
- Review of current literature on extracellular vesicle (EV) analysis in 3D in vitro models.
- Synthesis of findings regarding the application of organoids and other 3D models for EV research.
- Overview of translational and regulatory aspects relevant to EV therapeutics.
Main Results:
- Significant advancements have been made in utilizing 3D in vitro models for EV analysis.
- These models offer a more physiologically relevant platform for studying EV functions.
- Standardized and reproducible methods for EV analysis in 3D models are still lacking.
Conclusions:
- 3D in vitro models represent a promising frontier for extracellular vesicle (EV) research.
- Further development of standardized methods is crucial for the reliable analysis of EVs in these complex models.
- Addressing translational and regulatory challenges is essential for the commercialization of EV therapeutics.

